Clinical Trials · NCT01954147
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- Diabetes Care Center of Nanjing Military Command
- Enrollment
- 100
- Start date
- Oct 2013
- Locations
- 1 site, China
- Primary endpoint
- HbA1C